These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 25363455)
1. Primaquine: the risks and the benefits. Ashley EA; Recht J; White NJ Malar J; 2014 Nov; 13():418. PubMed ID: 25363455 [TBL] [Abstract][Full Text] [Related]
2. Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries. Recht J; Ashley EA; White NJ PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006230. PubMed ID: 29672516 [TBL] [Abstract][Full Text] [Related]
3. Single Low Dose Primaquine (0.25 mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient Subjects. Bancone G; Chowwiwat N; Somsakchaicharoen R; Poodpanya L; Moo PK; Gornsawun G; Kajeechiwa L; Thwin MM; Rakthinthong S; Nosten S; Thinraow S; Nyo SN; Ling CL; Wiladphaingern J; Kiricharoen NL; Moore KA; White NJ; Nosten F PLoS One; 2016; 11(3):e0151898. PubMed ID: 27010542 [TBL] [Abstract][Full Text] [Related]
4. Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common. White NJ; Qiao LG; Qi G; Luzzatto L Malar J; 2012 Dec; 11():418. PubMed ID: 23237606 [TBL] [Abstract][Full Text] [Related]
5. Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax. Milligan R; Daher A; Villanueva G; Bergman H; Graves PM Cochrane Database Syst Rev; 2020 Aug; 8():CD012656. PubMed ID: 32816320 [TBL] [Abstract][Full Text] [Related]
6. [Role of primaquine in malaria control and elimination in French-speaking Africa]. Briolant S; Pradines B; Basco LK Bull Soc Pathol Exot; 2017 Aug; 110(3):198-206. PubMed ID: 28417346 [TBL] [Abstract][Full Text] [Related]
7. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria. Rodrigo C; Rajapakse S; Fernando D Cochrane Database Syst Rev; 2020 Sep; 9(9):CD010458. PubMed ID: 32892362 [TBL] [Abstract][Full Text] [Related]
8. Single low-dose primaquine for blocking transmission of Plasmodium falciparum malaria - a proposed model-derived age-based regimen for sub-Saharan Africa. Taylor WR; Naw HK; Maitland K; Williams TN; Kapulu M; D'Alessandro U; Berkley JA; Bejon P; Okebe J; Achan J; Amambua AN; Affara M; Nwakanma D; van Geertruyden JP; Mavoko M; Lutumba P; Matangila J; Brasseur P; Piola P; Randremanana R; Lasry E; Fanello C; Onyamboko M; Schramm B; Yah Z; Jones J; Fairhurst RM; Diakite M; Malenga G; Molyneux M; Rwagacondo C; Obonyo C; Gadisa E; Aseffa A; Loolpapit M; Henry MC; Dorsey G; John C; Sirima SB; Barnes KI; Kremsner P; Day NP; White NJ; Mukaka M BMC Med; 2018 Jan; 16(1):11. PubMed ID: 29347975 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of G6PD deficiency and submicroscopic malaria parasites carriage in malaria hotspot area in Northwest, Tanzania. Manjurano A; Lyimo E; Kishamawe C; Omolo J; Mosha J; Donald M; Kazyoba P; Kapiga S; Changalucha J Malar J; 2023 Dec; 22(1):372. PubMed ID: 38062464 [TBL] [Abstract][Full Text] [Related]
10. Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission. Graves PM; Gelband H; Garner P Cochrane Database Syst Rev; 2014 Jun; (6):CD008152. PubMed ID: 24979199 [TBL] [Abstract][Full Text] [Related]
11. Mass primaquine treatment to eliminate vivax malaria: lessons from the past. Kondrashin A; Baranova AM; Ashley EA; Recht J; White NJ; Sergiev VP Malar J; 2014 Feb; 13():51. PubMed ID: 24502194 [TBL] [Abstract][Full Text] [Related]
15. Management of relapsing Plasmodium vivax malaria. Chu CS; White NJ Expert Rev Anti Infect Ther; 2016 Oct; 14(10):885-900. PubMed ID: 27530139 [TBL] [Abstract][Full Text] [Related]
16. G6PD deficiency: global distribution, genetic variants and primaquine therapy. Howes RE; Battle KE; Satyagraha AW; Baird JK; Hay SI Adv Parasitol; 2013; 81():133-201. PubMed ID: 23384623 [TBL] [Abstract][Full Text] [Related]
17. Spatial distribution of G6PD deficiency variants across malaria-endemic regions. Howes RE; Dewi M; Piel FB; Monteiro WM; Battle KE; Messina JP; Sakuntabhai A; Satyagraha AW; Williams TN; Baird JK; Hay SI Malar J; 2013 Nov; 12():418. PubMed ID: 24228846 [TBL] [Abstract][Full Text] [Related]
18. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria. Rajapakse S; Rodrigo C; Fernando SD Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD010458. PubMed ID: 25921416 [TBL] [Abstract][Full Text] [Related]
19. In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals. Shekalaghe SA; ter Braak R; Daou M; Kavishe R; van den Bijllaardt W; van den Bosch S; Koenderink JB; Luty AJ; Whitty CJ; Drakeley C; Sauerwein RW; Bousema T Antimicrob Agents Chemother; 2010 May; 54(5):1762-8. PubMed ID: 20194698 [TBL] [Abstract][Full Text] [Related]
20. Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria. Milligan R; Daher A; Graves PM Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012656. PubMed ID: 31274189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]